Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington
13/04/2026 05:52
April 13 (Reuters) - Piramal Pharma Ltd PIRM.NS: CLOSURE OF US FDA INSPECTION AT MANUFACTURING FACILITY AT LEXINGTON US FDA HAS ISSUED EIR FOR SAID MANUFACTURING FACILITY WITH VAI Source text: ID:nBSEbbHpn Further company coverage: PIRM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington